Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Koszalin
Clinical trial register · Poland

Clinical Trials in Koszalin, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2709 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
2709
Studies in scope
all four open statuses
1380
Recruiting now
open to new participants
510
Lead sponsors
across recruiting studies
Top sites
Warsaw 1318 Krakow 881 Poznan 697 Gdansk 663 Lodz 618
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca28 Merck Sharp & Dohme LLC22 Pfizer7 Hoffmann-La Roche7 Janssen Research & Development, LLC4 Bristol-Myers Squibb2 Eli Lilly and Company2 BioNTech SE2 Shanghai Junshi Bioscience Co., Ltd.1 Can-Fite BioPharma1 GlaxoSmithKline1 Bayer1 Genmab1 Jiangsu HengRui Medicine Co., Ltd.1 Shanghai Henlius Biotech1 Taiho Oncology, Inc.1 Daiichi Sankyo1 Janssen Pharmaceutica N.V., Belgium1
Site location
Warsaw1318 Krakow881 Poznan697 Gdansk663 Lodz618 Wroclaw526 Bydgoszcz525 Lublin525 Katowice510 Bialystok388 Olsztyn190 Rzeszów183 Szczecin183 Gdynia167 Gliwice121 Kielce117 Torun111 Opole106 Koszalin84 Siedlce81 Zabrze69 Elblag67 Otwock56 Przemyśl55 Chorzów53 Show all 264
All 264 locations
Target enrolment
to

Trials with a site in Koszalin

84 of 2709 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
AstraZeneca
Phase 3
1,330
Gdansk, Koszalin, Krakow, Lodz, Olsztyn, Poznan, Warsaw, Wroclaw
2026-09-15
Recruiting
AstraZeneca
Phase 3
915
Gdansk, Koszalin, Poznan, Siedlce, Skórzewo, Wroclaw
2026-07-16
Recruiting
AstraZeneca
Phase 1
40
Brzozów, Koszalin, Lublin, Olsztyn, Przemyśl
2026-03-31
Recruiting
AstraZeneca
Phase 3
2,130
Gdansk, Koszalin, Krakow, Lublin, Olsztyn, Warsaw
2026-02-03
Recruiting
Bristol-Myers Squibb
Phase 2/3
990
Krakow, Warsaw, Wieliszew, Opole, Brzozów, Gdansk, Gliwice, Koszalin
2025-12-31
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Bydgoszcz, Koszalin, Krakow, Skórzewo, Sosnowiec, Warsaw, Wrocaw
2025-12-12
Recruiting
Pfizer
Phase 3
800
Katowice, Koszalin, Krakow, Opole, Poznan
2025-12-11
Recruiting
Merck Sharp & Dohme LLC
Phase 2
150
Warsaw, Koszalin
2025-12-04
Recruiting
AstraZeneca
Phase 3
1,100
Koszalin, Krakow, Lodz, Olsztyn, Warsaw
2025-12-04
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
Skórzewo, Bydgoszcz, Krakow, Siedlce, Warsaw, Przemyśl, Koszalin
2025-11-26
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
DrugsRamucirumab·Rilvegostomig·Nab-paclitaxel·Pemetrexed
AstraZeneca
Phase 1/2
152
Koszalin, Lodz, Olsztyn
2025-11-24
Recruiting
Pfizer
Phase 2/3
982
Warsaw, Olsztyn, Koszalin, Poznan, Tomaszów Mazowiecki
2025-10-03
Recruiting
AstraZeneca
Phase 1/2
283
Koszalin, Piotrkow Trybunalski, Przemyśl
2025-10-01
Recruiting
Pfizer
Phase 3
1,000
Poznan, Wroclaw, Szczecin, Koszalin, Krakow, Lublin, Rzeszów
2025-09-28
Recruiting
Janssen Research & Development, LLC
Phase 3
1,203
Bialystok, Bydgoszcz, Koszalin, Warsaw
2025-09-02
Recruiting
AstraZeneca
Phase 3
700
Gdynia, Gliwice, Koszalin, Krakow, Piotrkow Trybunalski, Poznan, Rzeszów, Warsaw
2025-08-06
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Bydgoszcz, Warsaw, Bialystok, Słupsk, Olsztyn, Koszalin, Lodz
2025-07-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
477
Poznan, Warsaw, Rzeszów, Gliwice, Koszalin
2025-07-16
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
360
Poznan, Warsaw, Gdansk, Koszalin
2025-07-03
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Paraplatin
Merck Sharp & Dohme LLC
Phase 3
2,400
Bydgoszcz, Krakow, Wałbrzych, Warsaw, Bialystok, Słupsk, Olsztyn, Koszalin
2025-06-30
Recruiting
GlaxoSmithKline
Phase 1/2
346
Brzozów, Koszalin, Warsaw
2025-06-11
Recruiting
Merck Sharp & Dohme LLC
Phase 2
144
Poznan, Warsaw, Gdansk, Koszalin
2025-05-28
Active, closed
Merck Sharp & Dohme LLC
Phase 2
96
Poznan, Warsaw, Gdansk, Koszalin
2025-05-13
Recruiting
AstraZeneca
Phase 3
1,220
Bydgoszcz, Gdansk, Koszalin, Lublin, Olsztyn, Warsaw
2025-05-06
Recruiting
Hoffmann-La Roche
Phase 3
450
?ód?, Bialystok, Konin, Koszalin, Krakow, Lublin, Późna, Rzeszów
2025-04-09
Recruiting
Merck Sharp & Dohme LLC
Phase 2
90
Poznan, Warsaw, Gdansk, Koszalin
2025-03-30
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
270
Poznan, Krakow, Warsaw, Koszalin
2025-03-25
Recruiting
AstraZeneca
Phase 3
840
Bialystok, Gdansk, Koszalin, Lodz, Olsztyn, Przemyśl, Tomaszów Mazowiecki, Warsaw
2025-03-01
Recruiting
Daiichi Sankyo
Phase 3
726
Bielsko-Biala, Koszalin, Poznan, Warsaw
2025-02-27
Recruiting
BioNTech SE
Phase 3
621
Gdansk, Katowice, Konin, Koszalin, Krakow, Lodz, Lublin, Olsztyn
2025-02-03
Recruiting
BioNTech SE
Phase 2/3
1,580
Bialystok, Bydgoszcz, Gdansk, Gliwice, Katowice, Kielce, Koszalin, Krakow
2025-01-07
Active, closed
Pfizer
Phase 3
1,035
Krakow, Bialystok, Gdynia, Koszalin, Lodz
2025-01-06
Active, closed
Genmab
Phase 3
191
Koszalin, Krakow, Lodz, Skorzewo, Warsaw
2024-11-25
Recruiting
Shanghai Henlius Biotech
Phase 3
550
Brzozów, Gdansk, Koszalin, Lodz, Lublin, Otwock, Skorzewo, Słupsk
2024-11-22
Recruiting
Pfizer
Phase 3
900
Krakow, Wroclaw, Lublin, Warsaw, Koszalin, Opole, Piotrkow Trybunalski
2024-10-22
Active, closed
Pfizer
Phase 3
609
Grudziądz, Torun, Krakow, Wroclaw, Opole, Koszalin
2024-10-21
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Konin, Poznan, Bydgoszcz, Warsaw, Koszalin, Prabuty, Lodz
2024-10-07
Recruiting
AstraZeneca
Phase 3
788
Biała Podlaska, Koszalin, Lodz, Lublin, Poznan, Radom, Warsaw
2024-08-01
Active, closed
Merck Sharp & Dohme LLC
Phase 2
272
Bydgoszcz, Warsaw, Koszalin
2024-04-10
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
230
Poznan, Bydgoszcz, Warsaw, Koszalin, Kielce
2024-03-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,310
Bydgoszcz, Grudziądz, Torun, Siedlce, Koszalin, Szczecin, Kielce
2023-12-31
Active, closed
Merck Sharp & Dohme LLC
Phase 2
147
Bydgoszcz, Warsaw, Koszalin, Szczecin
2023-12-26
Active, closed
Hoffmann-La Roche
Phase 3
1,050
?ód?, Bydgoszcz, Gdynia, Gliwice, Kielce, Konin, Koszalin, Lublin
2023-12-11
Active, closed
AstraZeneca
Phase 3
1,898
Bydgoszcz, Koszalin, Poznan, Rzeszów, Warsaw, Wroclaw
2023-11-21
Active, closed
AstraZeneca
Phase 3
5,511
Bialystok, Biała Podlaska, Bydgoszcz, Gdansk, Gdynia, Koszalin, Krakow, Lodz
2023-10-05
Recruiting
Hoffmann-La Roche
Phase 3
230
Bydgoszcz, Gda?sk, Gdynia, Gliwice, Konin, Koszalin, Późna, Warsaw
2023-09-08
Active, closed
Janssen Research & Development, LLC
Phase 3
420
Bydgoszcz, Koszalin, Warsaw, Wroclaw
2023-08-31
Recruiting
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
NCT05727176Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement
DrugFutibatinib
Taiho Oncology, Inc.
Phase 2
120
Koszalin, Lublin, Otwock, Warsaw
2023-07-05
Recruiting
Hoffmann-La Roche
Phase 3
420
Bydgoszcz, Gdynia, Gliwice, Konin, Koszalin, Krakow, Rzeszów, Warsaw
2023-06-07
Recruiting
Hoffmann-La Roche
Phase 3
200
Gda?sk, Koszalin, Warsaw
2023-06-01
Active, closed
Hoffmann-La Roche
Phase 2
204
Koszalin, Krakow, Późna, Warsaw
2023-04-13
Recruiting
AstraZeneca
Phase 3
4,300
Bialystok, Grudziądz, Koszalin, Lodz, Lublin, Opole, Poznan, Racibórz
2023-03-31
Recruiting
Can-Fite BioPharma
Phase 3
471
Koszalin, Krakow, Mysłowice, Przemyśl, Warsaw, Wroclaw
2023-03-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
377
Warsaw, Olsztyn, Koszalin
2023-02-14
Active, closed
AstraZeneca
Phase 3
1,350
Bydgoszcz, Bystra, Grudziądz, Kielce, Koszalin, Olsztyn, Poznan, Przemyśl
2022-12-29
Active, closed
Eli Lilly and Company
Phase 3
8,000
Gdynia, Koszalin, Lodz, Opole, Oświęcim, Siedlce, Torun, Warsaw
2022-10-04
Active, closed
Hoffmann-La Roche
Phase 3
922
Gdansk, Konin, Koszalin, Opole, Pi?a, Późna, Rzeszów, Warsaw
2022-07-18
Active, closed
AstraZeneca
Phase 3
1,051
Bydgoszcz, Gdansk, Koszalin, Poznan, Siedlce, Tomaszów Mazowiecki, Warsaw
2022-02-07
Recruiting
Merck Sharp & Dohme LLC
Phase 1
830
Poznan, Warsaw, Gdansk, Koszalin
2021-12-17
Active, closed
AstraZeneca
Phase 3
927
Bialystok, Biała Podlaska, Bydgoszcz, Koszalin, Lublin, Rzeszów, Warsaw
2021-10-25
Active, closed
AstraZeneca
Phase 3
732
Bialystok, Gdansk, Gdynia, Konin, Koszalin, Lodz, Tomaszów Mazowiecki, Warsaw
2021-10-18
Active, closed
AstraZeneca
Phase 3
315
Bydgoszcz, Gdynia, Koszalin, Lodz, Poznan, Rzeszów, Tomaszów Mazowiecki, Warsaw
2021-06-30
Active, closed
Merck Sharp & Dohme LLC
Phase 2
302
Wroclaw, Warsaw, Rzeszów, Koszalin, Brzeziny
2021-06-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
808
Poznan, Siedlce, Warsaw, Przemyśl, Wrocław, Koszalin
2021-04-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,688
Konin, Poznan, Bydgoszcz, Radom, Warsaw, Koszalin
2021-04-14
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
496
Gdynia, Grudziądz, Kobylniki, Koszalin, Krakow, Poznan, Warsaw, Wroclaw
2021-03-18
Active, closed
AstraZeneca
Phase 3
1,371
Gdynia, Konin, Koszalin, Lodz, Lublin, Olsztyn, Poznan
2021-01-28
Active, closed
AstraZeneca
Phase 1/2
245
Bydgoszcz, Koszalin, Lodz, Lublin
2020-12-28
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Bydgoszcz, Elblag, Gdansk, Gdynia, Kielce, Koszalin, Lodz, Radom
2020-11-12
Active, closed
Bayer
Phase 4
654
Krakow, Wroclaw, Lublin, Warsaw, Koszalin
2020-11-09
Active, closed
AstraZeneca
Phase 3
866
Bydgoszcz, Koszalin, Krakow, Lodz, Rzeszów, Warsaw, Wroclaw
2020-07-24
Active, closed
AstraZeneca
Phase 3
1,012
Bydgoszcz, Gdansk, Koszalin, Lodz, Olsztyn, Poznan, Rzeszów, Torun
2020-07-13
Active, closed
Shanghai Junshi Bioscience Co., Ltd.
Phase 3
530
Gdansk, Koszalin, Krakow, Mysłowice, Poznan, Skórzewo, Warsaw
2020-06-29
Active, closed
AstraZeneca
Phase 2
452
Gdansk, Konin, Koszalin, Krakow, Warsaw
2020-06-03
Active, closed
Merck Sharp & Dohme LLC
Phase 3
520
Krakow, Siedlce, Koszalin
2020-05-19
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
450
Warsaw, Gdansk, Koszalin
2019-12-19
Recruiting
Merck Sharp & Dohme LLC
Observational
1,065
Warsaw, Gdansk, Koszalin
2019-12-19
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
Bydgoszcz, Koszalin, Krakow, Warsaw, Wroclaw
2019-06-11
Active, closed
AstraZeneca
Phase 3
1,063
Bialystok, Gdansk, Grudziądz, Koszalin, Krakow, Olsztyn, Ostrołęka, Poznan
2018-11-16
Active, closed
AstraZeneca
Phase 3
1,246
Bialystok, Gdansk, Grudziądz, Koszalin, Krakow, Olsztyn, Poznan, Radom
2018-09-27
Active, closed
AstraZeneca
Phase 3
1,018
Bialystok, Gdansk, Grudziądz, Koszalin, Piotrkow Trybunalski, Poznan, Warsaw, Wroclaw
2018-05-14
Active, closed
Janssen Research & Development, LLC
Phase 3
211
Chorzów, Koszalin, Lodz, Lublin, Warsaw
2018-04-17
Recruiting
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
NCT03460977Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)
DrugsMevrometostat·Xtandi·Itraconazole·Enzalutamide
Pfizer
Phase 1
453
Bydgoszcz, Koszalin, Krakow, Rzeszów, Warsaw
2018-04-17
Active, closed
AstraZeneca
Phase 3
669
Bialystok, Grudziądz, Koszalin, Lublin, Mrozy, Warsaw, Wroclaw
2017-01-02
Rows per page Showing 1–84 of 84
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-poland/city/koszalin

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,709 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 84 of those studies with a site in Koszalin.

How many clinical trials are recruiting in Koszalin?

45 of the 84 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 39 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Koszalin), 84 studies
PhaseStudiesRecruitingShare
Phase 3582869%
Phase 210411.9%
Phase 1/2869.5%
Phase 1333.6%
Phase 2/3333.6%
Observational111.2%
Phase 4101.2%

Most active sponsors

Lead sponsors with the most studies (Koszalin)
Lead sponsorStudiesRecruiting
AstraZeneca2812
Merck Sharp & Dohme LLC2213
Hoffmann-La Roche74
Pfizer75
Janssen Research & Development, LLC41
BioNTech SE22
Bristol-Myers Squibb22
Eli Lilly and Company21
Bayer10
Can-Fite BioPharma11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.